US Broker Ratings

Genmab A/S (GMAB) Stock Report: Attractive Growth Potential with 12.37% Upside for Biotechnology Investors

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, stands out with its strong growth trajectory and robust pipeline of antibody-based products aimed at treating cancer and other..

Guardant Health, Inc. (GH) Stock Analysis: A Promising Upside in the Precision Oncology Space

Guardant Health, Inc. (NASDAQ: GH), a trailblazer in the field of precision oncology, has been capturing investor attention with its innovative approach to cancer diagnostics and research. Headquartered in Palo..

Viatris Inc. (VTRS) Stock Analysis: Evaluating the 3.63% Dividend Yield Amidst Mixed Financial Metrics

Viatris Inc. (NASDAQ: VTRS), a global healthcare company specializing in both branded and generic drugs, has captured investors’ attention with its notable dividend yield of 3.63%. While this figure may..

Lantheus Holdings, Inc. (LNTH): Analyst Consensus Reveals a Robust 24.2% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, stands out in the specialty and generic drug manufacturing industry. Based in Bedford, Massachusetts, Lantheus is known for..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Uncovering a 63.98% Potential Upside with Innovative Sleep Apnea Solutions

Inspire Medical Systems, Inc. (NASDAQ: INSP) has captured the attention of investors with its innovative approach to treating obstructive sleep apnea (OSA), a condition that affects millions globally. Headquartered in..

Integer Holdings Corporation (ITGR) Stock Analysis: Evaluating Growth Potential in Healthcare Tech

Integer Holdings Corporation (NYSE: ITGR), a significant player in the medical device sector, presents an intriguing opportunity for investors eyeing the healthcare industry. With a market capitalization of $3.02 billion,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a 65.86% Potential Upside in the Healthcare Sector

As investors continue to seek opportunities in the dynamic healthcare sector, Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the medical instruments and supplies industry, stands out with a..

ADMA Biologics Inc (ADMA) Stock Analysis: Unlocking a 53% Upside Potential

ADMA Biologics Inc (NASDAQ: ADMA) is emerging as a compelling prospect for investors seeking exposure to the biotechnology sector. With a market capitalization of $3.99 billion, this U.S.-based healthcare player..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a Robust 15% Potential Upside

Globus Medical, Inc. (GMED) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Audubon, Pennsylvania, the company specializes in developing and commercializing cutting-edge..

Amgen Inc. (AMGN) Stock Analysis: A Healthcare Giant with a 12.4% Revenue Growth and Robust Dividend Yield

Amgen Inc. (AMGN), a stalwart in the healthcare sector, continues to assert its dominance as a leading player in the drug manufacturing industry. With a market capitalization of $185.64 billion,..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 12.94% Potential Upside Amidst Robust Pipeline

Ionis Pharmaceuticals, Inc. (IONS), a key player in the biotechnology sector, is currently captivating investor attention with its strong pipeline and substantial market presence. As a commercial-stage biotechnology company, Ionis..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 20% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, operates as a plasma therapeutic company with significant operations in Spain, the United States, Canada, and globally. With a..

Teleflex Incorporated (TFX): Investor Outlook Highlights Potential 26.97% Upside

Teleflex Incorporated (NYSE: TFX), a key player in the Healthcare sector, particularly within the Medical Instruments & Supplies industry, has captured investor attention with its diverse portfolio of single-use medical..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 61% Potential Upside and Strong Buy Ratings

For investors with a penchant for the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents an intriguing opportunity marked by substantial growth potential and robust market positioning. With a market..

McKesson Corporation (MCK) Investor Outlook: Analyzing a 14.85% Upside Potential

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a titan in the medical distribution industry with a market capitalization of $102.02 billion. As investors seek resilient..

Repligen Corporation (RGEN) Stock Analysis: A Closer Look at Its 17.59% Potential Upside and Growth Trajectory

Repligen Corporation (NASDAQ: RGEN) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $9.14 billion, the company..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unpacking a Promising 28% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, has captured investor attention with a market capitalization of $10.25 billion and a promising potential upside of 28.29%...

HCA Healthcare, Inc. (HCA) Stock Analysis: Growth Momentum Amidst Analyst Optimism

HCA Healthcare, Inc. (NYSE: HCA) stands as a significant player in the U.S. healthcare industry, commanding a robust market capitalization of $110.18 billion. Specializing in medical care facilities, HCA operates..

Medtronic plc (MDT) Stock Analysis: Strong Buy Signals Amidst a 9.24% Upside Potential

Medtronic plc (MDT), a titan in the healthcare sector, specifically in the medical devices industry, has garnered attention with its substantial market capitalization of $129.39 billion. As an Ireland-based company,..

Humana Inc. (HUM) Stock Analysis: Examining Growth Potential Amidst Healthcare Sector Dynamics

For investors navigating the healthcare sector, Humana Inc. (NYSE: HUM) presents a compelling opportunity. As a key player in the healthcare plans industry, Humana commands a substantial market presence in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds